Identification of a Common Variant for Coronary Heart Disease at PDE1A Contributes to Individualized Treatment Goals and Risk Stratification of Cardiovascular Complications in Chinese Patients With Type 2 Diabetes.
Tam CHT, Lim CKP, Luk AOY, Shi M, Man Cheung H, Ng ACW, Lee HM, Lau ESH, Fan B, Jiang G, Kong APS, Ozaki R, Chow EYK, Lee KF, Siu SC, Hui G, Tsang CC, Lau KP, Leung JYY, Cheung EYN, Tsang MW, Kam G, Lau IT, Li JKY, Yeung VTF, Lau E, Lo S, Fung S, Cheng YL, Chow CC, Fan X, Chan TF, Yip KYL, Lok S, Yu W, Tsui SKW, Lan HY, Szeto CC, Tang NLS, Tomlinson B, Huang Y, Jenkins AJ, Keech A, So WY, Chan JCN, Ma RCW; Hong Kong Diabetes Biobank Study Group, FIELD Study Investigators; TRansomics ANalysis of Complications and ENdpoints in Diabetes (TRANSCEND) Consortium.
Tam CHT, et al. Among authors: tsui skw.
Diabetes Care. 2023 Jun 1;46(6):1271-1281. doi: 10.2337/dc22-2331.
Diabetes Care. 2023.
PMID: 37125963
Free PMC article.